Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Quest Diagnostics Incorporated (DGX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
154.95+5.43 (+3.63%)
At close: 1:00PM EST
155.00 +0.05 (+0.03%)
After hours: 04:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close149.52
Open151.73
Bid155.93 x 900
Ask157.00 x 800
Day's Range151.53 - 156.56
52 Week Range113.36 - 160.56
Volume1,115,229
Avg. Volume1,286,811
Market Cap19.008B
Beta (5Y Monthly)1.00
PE Ratio (TTM)9.32
EPS (TTM)16.63
Earnings DateFeb 02, 2022 - Feb 07, 2022
Forward Dividend & Yield2.48 (1.60%)
Ex-Dividend DateJan 18, 2022
1y Target Est161.47
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DGX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Quest Diagnostics Incorporated
    Analyst Report: Quest Diagnostics, Inc.Quest Diagnostics is a leading global provider of clinical diagnostic laboratories and services that help to identify and treat disease and improve healthcare management. The company incorporated in Delaware in 1990; its predecessor companies date back to 1967. Quest is based in Secaucus, New Jersey, employs roughly 50,000 people, and is a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    26 days agoArgus Research
View more
  • Zacks

    Quest Diagnostics' (DGX) COVID-19 Testing Demand Up in 3 Weeks

    According to Quest Diagnostics (DGX), as the nation is entering the holiday season, the importance of testing service is gaining more importance with regard to minimizing the risk of community exposure of COVID-19.

  • Simply Wall St.

    Those who invested in Quest Diagnostics (NYSE:DGX) five years ago are up 86%

    When you buy and hold a stock for the long term, you definitely want it to provide a positive return. But more than...

  • InvestorPlace

    7 Stocks to Buy as America Lifts Its Travel Ban

    While virtually every sector suffered a massive decline in business activity, the most conspicuous devastation occurred in the travel industry. According to the U.S. Bureau of Transportation Statistics, air passenger revenue miles dropped a staggering 96% between February and May of 2020. At the time, very few investors — if any — were thinking about stocks to buy in this market segment. To be fair, air passenger miles are still deflated relative to historical norms. However, the Covid-19 vaccin

Advertisement
Advertisement